Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Research & Development: 2009-2024

Historic Research & Development for Rockwell Medical (RMTI) over the last 15 years, with Dec 2024 value amounting to $1,000.

  • Rockwell Medical's Research & Development fell 99.40% to $1,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $681,000, marking a year-over-year decrease of 38.48%. This contributed to the annual value of $19,000 for FY2024, which is 98.28% down from last year.
  • As of Q4 2024, Rockwell Medical's Research & Development stood at $1,000, which was down 94.44% from $18,000 recorded in Q1 2024.
  • In the past 5 years, Rockwell Medical's Research & Development ranged from a high of $2.4 million in Q2 2021 and a low of $1,000 during Q4 2024.
  • Over the past 3 years, Rockwell Medical's median Research & Development value was $223,000 (recorded in 2023), while the average stood at $424,400.
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 266.40% in 2020, then tumbled by 99.40% in 2024.
  • Quarterly analysis of 5 years shows Rockwell Medical's Research & Development stood at $1.9 million in 2020, then fell by 27.49% to $1.4 million in 2021, then crashed by 88.78% to $156,000 in 2022, then climbed by 7.69% to $168,000 in 2023, then slumped by 99.40% to $1,000 in 2024.
  • Its Research & Development stands at $1,000 for Q4 2024, versus $18,000 for Q1 2024 and $168,000 for Q4 2023.